Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

OncoSec Medical Inc shares up on FDA Fast Track approval

Monday, February 27, 2017 8:55
% of readers think this story is Fact. Add your two cents.

OncoSec Medical Inc (NASDAQ:ONCS) was up 3.45% to US$1.44 in early deals as it was granted  FDA fast track designation for it its ImmunoPulse  IL-12 to treat metastatic melanoma.

The move further validates the group’s clinical development program as it’s about to start a Phase 2b clinical trial, it said.

“With the number of melanoma patients now being treated with either pembrolizumab or nivolumab in either the first- or second-line settings, there will be an increasing number of patients who will not respond to therapy.

“Thus, there is a clear need for treatments that can rescue these patients and help them benefit from these immunotherapies,” said OncoSec president and chief executive Punit Dhillon.

“With the recent presentation of our interim data from our ongoing combination study with pembrolizumab in patients predicted not to respond to single-agent anti-PD-1 therapy, we are increasingly confident in ImmunoPulse IL-12 to potentially convert ‘cold’ tumors to ‘hot’ tumors to effectively and safely improve the response rates of these patients.”

The FDA set up the fast track program to expedite the review of new drugs intended to treat serious or life-threatening conditions, and address unmet medical needs.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global

Top Alternative



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.